Finance

Beta
Lists
524636:BOM
Oxygenta Pharmaceutical Ltd
₹48.50
-5.75%
(-2.96) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524636...
Open
₹52.50
High
₹52.50
Low
₹48.21
Mkt. cap
1.79B
Avg. vol.
9.50K
Volume
4.42K
52-wk high
₹129.60
52-wk low
₹43.00
EPS
-₹4.75
No. of employees
175
Open
₹52.50
High
₹52.50
Low
₹48.21
Mkt. cap
1.79B
Avg. vol.
9.50K
Volume
4.42K
52-wk high
₹129.60
52-wk low
₹43.00
EPS
-₹4.75
No. of employees
175
News stories
From sources across the web
About Oxygenta Pharmaceutical Ltd
CEO-
Employees175
Founded1990
Headquarters-
SectorPharmaceutical industry
Websiteoxygentapharma.com
Last report
May 23, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
496.14M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
151.35M
143.02M
339.31M
496.14M
Cost of goods sold
188.17M
162.30M
353.09M
317.79M
Cost of revenue
188.17M
162.30M
353.09M
317.79M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.02M
20.35M
18.90M
17.18M
Operating expense
39.94M
35.04M
35.58M
174.80M
Total operating expenses
228.12M
197.34M
388.67M
492.58M
Operating income
-76.77M
-54.32M
-49.36M
3.56M
Other non operating income
1.69M
-562.00K
1.00K
1.73M
EBT including unusual items
-81.48M
-64.38M
-63.26M
-12.33M
EBT excluding unusual items
-81.36M
-64.38M
-63.26M
-12.80M
Income tax expense
-20.42M
-15.07M
-14.84M
4.24M
Effective tax rate
25.06%
23.41%
23.45%
-34.38%
Other operating expenses
11.45M
6.12M
8.08M
160.03M
Net income
-61.06M
-49.30M
-48.43M
-16.58M
Net profit margin
-40.34%
-34.47%
-14.27%
-3.34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6.28M
-9.50M
-13.91M
-18.08M
Net interest expenses
-6.28M
-9.50M
-13.91M
-18.08M
Depreciation and amortization charges
8.47M
8.57M
8.59M
-2.41M
EBITDA
-67.73M
-45.80M
-47.32M
9.36M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer